Pradžia › Lėtinė inkstų liga › Džordžija
Lėtinė inkstų liga klinikiniai tyrimai Džordžija
16 tyrimai dėl Lėtinė inkstų liga ieško dalyvių vietose Džordžija.
Miestai Džordžija
Oficialus tyrimo tekstas (anglų kalba)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #29, Augusta
- Investigator Site # 1, Lawrenceville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07268638A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- North Georgia Clinical Research, Woodstock
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07783802A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Atlanta
- Research Site, Austell
- Research Site, Brunswick
- ir dar 5
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Brunswick
- Research Site, East Point
- Research Site, Macon
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07624305Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Privia Medical Group of Georgia, LLC, Savannah
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07271186A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Austell
- Research Site, Columbus
- Research Site, East Point
- ir dar 1
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07753993SPYRAL GEMINI Pilot Study
- Piedmont Heart Institute, Atlanta
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-06-24 · NCT06907147Study of BHV-1400 in IgA Nephropathy
- Site-008, Lawrenceville
Renkami dalyviai1 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07054684Sympatholysis in Chronic Kidney Disease
- Atlanta VA Medical Center, Decatur
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-05-18 · NCT02411773Neurovascular Transduction During Exercise in Chronic Kidney Disease
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital, Atlanta
- Atlanta VA Health Care System, Decatur
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-05-18 · NCT02947750Ferric Citrate and Chronic Kidney Disease in Children
- Emory University, Atlanta
Renkami dalyviai2 fazė
Amžius nuo 6 iki 18 · Visoms lytims · Atnaujinta 2026-04-17 · NCT04741646Shingrix in Renal Transplant Recipients
- Emory University, Atlanta
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-04-08 · NCT04128189A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- Nephrology & Hypertension Specialists, Dalton
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-01-29 · NCT06933472A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Piedmont Augusta, Augusta
Renkami dalyviai
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2025-12-22 · NCT04671771Mindfulness in Chronic Kidney Disease
- Atlanta VA Medical Center, Atlanta
Renkami dalyviai
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2025-10-21 · NCT04099992Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
- Emory Clinic, Atlanta
- Atlanta VA Medical Center, Decatur
Renkami dalyviai2 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2025-10-21 · NCT05928936Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.